News | October 01, 2008

CardioNet Launches Enhanced Reporting Package for the Treatment of Atrial Fibrillation

October 2, 2008 - Wireless medical technology company CardioNet Inc. today released its new atrial fibrillation (AF) reporting package to enhance its current AF management program.

The CardioNet AF Management Program offers a comprehensive tool to the physician for the diagnosis, treatment and management of their AF patients. The program provides physicians with a flexible monitoring program to evaluate the clinical efficacy of catheter and surgical ablation procedures allowing improved management of these post surgical patients.

The company said reporting enhancements will strengthen CardioNet’s current proprietary correlated Heart Rate Trend Chart and AF Burden Graph by providing detailed atrial fibrillation statistics, including the duration of AF episodes, the percentage of time that a patient is in AF over a 24-hour period, and heart rate trends while the patient is in AF.

The company said the CardioNet System is widely utilized by physicians and is proven to be nearly three times superior at detecting clinically significant atrial fibrillation1, a condition which affects 2.2 million people in the U.S.

For more information: www.cardionet.com


Related Content

News

Feb. 6, 2026 — Abbott has announced new clinical data from two late-breaking presentations at AF Symposium in Boston ...

Home February 06, 2026
Home
News

Jan. 20, 2026 — Abbott has received CE Mark in Europe for the TactiFlex Duo Ablation Catheter, Sensor Enabled to treat ...

Home January 22, 2026
Home
News

Jan. 20, 2026 — Kardium Inc. has announced the publication of the PULSAR clinical trial results in the Journal of the ...

Home January 21, 2026
Home
Feature | Kyle Hardner

Robotic Magnetic Navigation (RMN) emerged two decades ago as an alternative approach to performing complex ablation ...

Home January 09, 2026
Home
News

Jan. 6, 2026 — Stereotaxis, a supplier of surgical robotics for minimally invasive endovascular intervention, has ...

Home January 06, 2026
Home
News

Oct. 10, 2025 — Johnson & Johnson MedTech, in collaboration with the Heart Rhythm Clinical and Research Solutions, LLC ...

Home October 13, 2025
Home
News

Sept. 2, 2025 — Johnson & Johnson MedTech has announced acute safety and effectiveness results from the Varipure ...

Home September 05, 2025
Home
News

Sept. 3, 2025 — Kardium Inc. recently announced it has received pre-market approval (PMA) for the Globe Pulsed Field ...

Home September 03, 2025
Home
News

July 14, 2025  –  Johnson & Johnson MedTech has announced U.S. Food and Drug Administration (FDA) approval of an update ...

Home July 14, 2025
Home
News

July 7, 2025 — Catheter ablation is a minimally invasive treatment for abnormal heart rhythms. It is often successful in ...

Home July 09, 2025
Home
Subscribe Now